This is a regulatory disclosure filed with BSE Limited pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023.
The Board of Directors of Dolphin Medical Services Limited, at its meeting held on July 25, 2026, considered and approved the following item based on the recommendations of the Nomination and Remuneration Committee and the Audit Committee:
- Accepted the resignation of Mr. Vaishnavi Sharma from the offices of Company Secretary, Compliance Officer, and Chief Financial Officer (CFO) of the Company. The resignation is effective from the close of business hours on July 24, 2026.
The Board placed on record its appreciation for the services rendered by Mr. Vaishnavi Sharma during his tenure.
The required disclosures as per Regulation 30 and Schedule III, Part A, Para A(7) of the SEBI Listing Regulations are provided in the enclosed Annexure-A. The details from the annexure are:
- Reason for change: Resignation as Company Secretary and CFO.
- Date of cessation: July 24, 2026.
- Brief profile and disclosure of relationships between directors are noted as not applicable.
The Board meeting commenced at 4:30 P.M. (IST) and concluded at 5:00 P.M. (IST).
The letter is signed by Director Rajesh Kumar Mallour (DIN: 08125774).